Project Oncology® - Programs - Prova Education

Episodes 1-16 of 17

- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
5
CME/CE
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
- Charles E. Geyer, Jr., MD, FACP
  Peer
- Hope S. Rugo, MD
  Peer
3
CME/CE
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
0.25 credits
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
0.25 credits
- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
7
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
7
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
9
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Ca...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
19
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
11
CME/CE
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
9
CME/CE
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
8
CME/CE
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
0.25 credits
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
5
CME/CE
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
0.25 credits
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
5
CME/CE
Keeping Pace: The Role of Immunotherapy After Disease Progression
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
- Warner K. Huh, MD
  Peer
- Deborah K. Armstrong, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
16
CME/CE
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
- Mark A. Socinski, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
8
CME/CE
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
3
FDA Drug Information Updates
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
- Shira Johnson, MD
  Peer
- Robert Vonderheide, MD
  Peer
25
Medical Breakthroughs from Penn Medicine
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
- John J. Russell, MD
  Peer
- Harish Lavu, MD
  Peer
10
Project Oncology®
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Pancreatic Cancer: The Hunt to Catch a Silent Killer

Prev
1
2
Next

1/2